A review of antibody-based therapeutics targeting G protein-coupled receptors: an update

CJ Hutchings - Expert Opinion on Biological Therapy, 2020 - Taylor & Francis
Introduction G protein-coupled receptors (GPCRs) play key roles in many biological
functions and are linked to many diseases across all therapeutic areas. As such, GPCRs …

Of Lymph Nodes and CLL cells: deciphering the role of CCR7 in the pathogenesis of CLL and understanding its potential as therapeutic target

C Cuesta-Mateos, JR Brown, F Terrón… - Frontiers in …, 2021 - frontiersin.org
The lymph node (LN) is an essential tissue for achieving effective immune responses but it is
also critical in the pathogenesis of chronic lymphocytic leukemia (CLL). Within the multitude …

Human amnion-derived mesenchymal stem cells attenuate xenogeneic graft-versus-host disease by preventing T cell activation and proliferation

Y Tago, C Kobayashi, M Ogura, J Wada… - Scientific Reports, 2021 - nature.com
Acute graft-versus-host disease (GVHD) is characterized by severe tissue damage that is a
life-threatening complication of allogeneic hematopoietic stem cell transplantation. Due to …

[PDF][PDF] CCR7 in blood cancers–review of its pathophysiological roles and the potential as a therapeutic target

C Cuesta-Mateos, F Terrón, M Herling - Frontiers in Oncology, 2021 - frontiersin.org
According to the classical paradigm, CCR7 is a homing chemokine receptor that grants
normal lymphocytes access to secondary lymphoid tissues such as lymph nodes or spleen …

Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: the paradigm of CLL

C Cuesta-Mateos, R Juárez-Sánchez, T Mateu-Albero… - MAbs, 2021 - Taylor & Francis
Lymph node (LN) is a key tissue in the pathophysiology of mature blood cancers, especially
for chronic lymphocytic leukemia (CLL). Within the multiple de-regulated pathways affecting …

Insights into mechanisms of graft-versus-host disease through humanised mouse models

A Elhage, C Sligar, P Cuthbertson, D Watson… - Bioscience …, 2022 - portlandpress.com
Graft-versus-host disease (GVHD) is a major complication that occurs following allogeneic
haematopoietic stem cell transplantation (HSCT) for the treatment of haematological cancers …

[HTML][HTML] Evaluation of therapeutic targeting of CCR7 in acute graft-versus-host disease

C Cuesta-Mateos, I Portero-Sainz… - Bone Marrow …, 2020 - nature.com
Graft-versus-host disease (GVHD) is the main complication after allogeneic hematopoietic
stem cell transplantation. We previously unveiled a correlation between proportions of CC …

Development of a human antibody that exhibits antagonistic activity toward CC chemokine receptor 7

MS Jang, NSB Ismail, YG Yu - Antibody Therapeutics, 2022 - academic.oup.com
Background CC chemokine receptor 7 (CCR7) is a member of G-protein-coupled receptor
family and mediates chemotactic migration of immune cells and different cancer cells …

The immunobiology and clinical management of acute graft versus host disease after allogeneic transplant

K Chen - 2022 - search.proquest.com
Alloreactivity between donor cells against disparate host tissue is a natural and normal
physiologic phenomenon after engraftment. Consequently, GVHD is a universally expected …